Product Information
OXCARBAZEPINE 300 MG/5 ML SUSP is a generic product labeled by Advagen Pharma Ltd., priced at $0.1168 per ML under NDC 72888007414. Its NADAC has been published 98 times since Oct 9, 2024.
FDA first approved this application on Aug 30, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/5mL
Manufacturer
Advagen Pharma Ltd.NDC
72888007414
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215726FDA Approved
8/30/2022
TE Code
AB
On Market Since
8/31/2022
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has been published 98 times since Oct 9, 2024, and over the history we have for it it has declined 56.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1168 per ML |
|---|---|
| All-time high | $0.2704 (Oct 16, 2024) |
| All-time low | $0.1168 (Aug 19, 2026) |
| 52-week high | $0.1754 |
| 52-week low | $0.1168 |
| Median price | $0.1709 |
| Average price | $0.1833 |
| Largest weekly change | -18.4% (Nov 20, 2024) |
| Weeks tracked | 98 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the OXCARBAZEPINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG/5 ML SUSP, manufactured by Advagen Pharma Ltd., is $0.1168 per ML (NDC 72888007414), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE 300 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has declined 56.8%. It has been tracked across 98 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG/5 ML SUSP?
Since Oct 9, 2024, the NADAC for OXCARBAZEPINE 300 MG/5 ML SUSP has ranged from a low of $0.1168 (Aug 19, 2026) to a high of $0.2704 (Oct 16, 2024), with a median of $0.1709 per ML.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of OXCARBAZEPINE 300 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OXCARBAZEPINE 300 MG/5 ML SUSP?
OXCARBAZEPINE 300 MG/5 ML SUSP (NDC 72888007414) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.